Introduction {#sec1}
============

An efficient amino acid-derived nanoscale delivery method that facilitates oral delivery and cellular uptake of biopesticides that is biodegradable could greatly reduce the environmental load of active ingredients currently employed in agriculture. The Tomich lab has developed such a delivery agent. It is a self-assembling cationic nanocapsule composed of branched amphiphilic peptides (BAPs). As the peptides anneal, they form peptide bilayer-delimited capsules capable of encapsulating solutes in an aqueous environment. These BAP capsules (BAPCs) are prepared from two branched peptides---bis(Ac-FLIVI)-K-KKKK-CO-NH~2~ (CAS RN 1492039-67-4) and bis(Ac-FLIVIGSII)-K-KKKK-CO-NH~2~ (CAS RN 1492039-68-5).^[@ref1]^ The two peptides can assemble either singly or together using different assembly temperatures to alter the sizes of the nanocapsules.^[@ref2]^ Fully formed BAPCs range in diameter from 10 to \>500 nm depending on the annealing conditions.^[@ref3]^ BAPCs encapsulating fluorescent dyes are taken up by several epithelial cell lines, including HeLa (CCL-2), HEK-293 (CRL-11268), CasKi (CRL-1550), and N/N 1003A rabbit lens epithelial cells, through the endocytic pathway and then become localized in the perinuclear space.^[@ref4],[@ref5]^ They show minimal cytotoxicity to cultured HeLa cells.^[@ref6]^ In all previous studies, BAPCs have proven to be resistant to cellular degradative machinery and encapsulated active ingredients were not released from the capsules.^[@ref5]^ This lack of break down currently limits the utility of BAPCs for encapsulated drug delivery.

The cation surface of these nanoparticles can also bind and deliver a variety of nucleic acids. BAPCs were used in insects for oral delivery of dsRNAs directed to silence genes involved in the protein refolding pathway.^[@ref7]^ If the capsules are to be deployed in the environment, they need to be biodegradable to avoid environmental accumulation.

For this study, the common soil fungus *Aspergillus nidulans* was chosen to demonstrate fungal biodegradation of BAPCs. The *Aspergillus* genus is ubiquitous and very frequently occurs in soil.^[@ref8]−[@ref11]^ A well-known characteristic of fungi is the secretion of extracellular proteases for breaking down proteins in the surrounding environment for nutrient acquisition, making them excellent candidates to possess BAPC peptide capsule degradation capability.^[@ref12]^ Here, we show that this fungus degrades BAPCs. It can be inferred that the capsules would be broken down in the soil and, therefore, will not build up in the environment. It is important to note that proteases are conserved and therefore other species are expected to have similar BAPC degradation properties.

Results and Discussion {#sec2}
======================

To determine whether *A. nidulans* can degrade the peptide capsules, water soluble thiourea (TU), an analogue of urea known to be toxic when taken up by *A. nidulans*,^[@ref13]^ was encapsulated during BAPC formation and used to assess whether TU could be released from the BAPCs and cause growth inhibition on *A. nidulans* spread plates ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). We reasoned that the peptide capsules are likely to be degraded by proteases, and therefore used media containing milk as a de-repressing nitrogen source known to favor protease expression.^[@ref12]^[Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A shows the results of treating wild type MH1 with the TU-encapsulated BAPCs compared with water-encapsulated BAPCs. The lawn of *A. nidulans* growth is visible as the green color of the asexual spores (conidia) when treated with water-BAPCs, while treatment with TU-BAPCs conferred a zone of growth inhibition at the center of the plate (mean diameter ± standard error = 38.4 ± 4.36 mm) characterized by mycelium with reduced conidiation (asexual spore production) and displaying a brown pigmentation reaction encircled by a less intense green color, typical of reduced conidiation. A level of background growth occurs within the zone of TU-BAPC inhibition as the fungus must grow prior to producing the degrading enzymes that release the TU. Because the BAPCs were thoroughly washed to remove any surface-bound TU, the observed growth inhibition suggests that the contents of the BAPCs were released through the disassembly of the peptide bilayer through the action of one or more proteases.

![Degradation of BAPCs containing TU leads to growth inhibition on *A. nidulans* spread plates. (A) MH1 (wild type, WT) spread on 1% milk plates. −40 μL of BAPCs encapsulating water, left, 40 μL of BAPCs encapsulating 1.865 M TU, right, were spotted at the center of the plate. (B) MK85 (*xprG1*) spread on 1% milk plates---left, 40 μL of BAPCs encapsulating water, right, 40 μL of BAPCs encapsulating TU. The arrowheads indicate the zone of inhibition.](ao9b03245_0001){#fig1}

![Spread Plate Assay for BAPC Degradation](ao9b03245_0003){#sch1}

To confirm that fungal proteases are involved, cultures were established using the mutant strain, MK85 (*xprG1*). This strain has increased extracellular protease production because of a gain-of-function mutation in the p53-like transcription factor XprG, which regulates the expression of extracellular protease genes.^[@ref14],[@ref15]^ The results of this experiment showed a larger and clearer zone of inhibition for MK85 (mean diameter ± standard error = 45.6 ± 3.52 mm) than for the wild type strain MH1 ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B).

Next, we developed an assay for the degradation of TU-containing BAPCs by MH1 (wild type) or MK85 (*xprG1*) fungal cells in liquid culture ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The liquid cultures were prepared, then the filtered fungus-free media was concentrated, and spotted at the center of a wild type MH1 spread plate ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A,B). No growth inhibition was evident from the filtrate from either the wild type or *xprG1* water-BAPC or no BAPC treatment. In contrast, a zone of mild growth inhibition, evident as reduced green density of conidiation at the center of the plate was observed for the wild type TU-BAPC filtrate ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A). This indicates that secreted proteases were present in the media of the liquid cultures and that they had broken down TU-encapsulated BAPCs thereby releasing the fungicide. A larger zone of inhibition was observed for the TU-BAPC-treated filtrate from the MK85 (*xprG1*) culture ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B). This is consistent with the involvement of proteases in BAPC degradation. It is important to note the possibility of an alternative interpretation that the BAPCs could have been degraded intracellularly with the subsequent excretion of the fungicide into the media. However, because of the known elevated expression of extracellular proteases in the *xprG1* gain-of-function mutant, we favor the interpretation that the degradation is performed by an extracellular protease.

![Concentrated media from liquid cultures grown with BAPC-containing TU inhibits *A. nidulans* growth on spread plates. (A) Media from MH1 (WT) 1% milk liquid cultures spotted on MH1 1% milk plates. Left to right-untreated (no BAPCs), BAPCs encapsulating water, BAPCs encapsulating TU. (B) Media from MK85 (*xprG1*) 1% milk liquid cultures spotted on MH1 (WT) 1% milk plates, left to right---untreated (no BAPCs), BAPCs encapsulating water, BAPCs encapsulating TU. The arrowheads indicate the zone of inhibition. Photographs in A and B were taken under different lighting; adjustments were made to brightness and contrast.](ao9b03245_0002){#fig2}

![Liquid Culture Assay for BAPC Degradation](ao9b03245_0004){#sch2}

Conclusions {#sec3}
===========

BAPCs are being tested for their ability to deliver nucleic acids designed to be biocides. In all animal species tested, the BAPCs remain intact and show no cytotoxicity when given at clinical dosages.^[@ref7]^ An early concern has been the accumulation of the peptide nanoparticles in the environment, should they be used on an agricultural scale. Based on our experiments, it is clear that a wild type ubiquitous soil fungus can proteolyze these structures. Furthermore, the increased diameter of the zone of inhibition observed with the MK85 gain-of-function mutant, which was originally selected for elevated extracellular protease production, provided evidence that the fungus produced an extracellular protease capable of BAPC degradation. The candidate enzyme(s) responsible for BAPC degradation are being sought. ε-Poly-[l]{.smallcaps}-lysine-degrading enzyme from *Streptomyces albulus* (BAE53412.2) is known to break down the bond found in the branch point in BAPCs.^[@ref16]^ Preliminary sequence database searches reveal sequence similarity to several hypothetical proteases in *A. nidulans*. There are many other species with potential orthologues to the assumed BAPC-degrading enzyme according to sequence similarity.

There is much work to be done to give a comprehensive molecular analysis of BAPC breakdown. BAPCs can now be considered biodegradable because of the ability of *A. nidulans* to degrade the capsules and release their contents. *A. nidulans*, like other *Aspergillus* species, is widely distributed in the soil in a range of biomes and latitudes.^[@ref10]^ Studies of fungal density in cultivated agricultural soils report filamentous fungi to occur at 10^4^ to 10^5^ colony forming units per gram of soil.^[@ref17],[@ref18]^ Our results, when considered with the abundance of Aspergilli in soils and longer environmental time-frames than the two-day time-point used in our studies, suggest that the accumulation of BAPCs in the environment should not present a sizable hurdle to their introduction as biocide carriers. The accumulation of nanoparticles in the soil will be avoided if BAPCs are used to deliver biocides composed of biodegradable nucleic acids.

Experimental Section {#sec4}
====================

BAPC Formation {#sec4.1}
--------------

The two self-assembling peptides, bis(Ac-FLIVI)-K-KKKK-CO-NH~2~ and bis(Ac-FLIVIGSII)-K-KKKK-CO-NH~2~, were chemically synthesized as previously described.^[@ref4]^ BAPCs were prepared by mixing equimolar concentrations (1 mM each) of the two branched peptides dissolved in trifluoroethanol. Under these conditions the peptides do not associate and remain monomeric. They were dried in vacuo and rehydrated dropwise in sterile water for controls or with water containing the active ingredient. The nascent particles were subjected to a temperature shift protocol previously described yielding 20--30 nm nanoparticles.^[@ref3]^ Because it takes ∼1600 peptides to make one BAPC, the final concentration was 1.3 μM. BAPCs loaded with the active ingredient were dried and then resuspended in 50 μL of water at a final concentration of 20 μM BAPCs.

Fungicide Encapsulation {#sec4.2}
-----------------------

Water soluble TU (Sigma, St. Louis, MO) was encapsulated at a concentration of 1.865 M during BAPC assembly. The TU-encapsulated BAPCs were washed several times to remove externally bound active ingredient, as previously described.

*A. nidulans* Strains and Growth {#sec4.3}
--------------------------------

*A. nidulans* strain MH1 (*biA1 veA1*) was used as wild type (M.J. Hynes, University of Melbourne; deposited in the Fungal Genetics Stock Center (FGSC), Manhattan KS, as FGSC A2291).^[@ref19]^*A. nidulans* MK85 (*biA1 xprG1 niiA4 veA1*) is an *xprG1* gain-of-function mutant de-repressed for extracellular proteases (M.E. Katz, University of New England; FGSC A1630).^[@ref14],[@ref15]^ Fungal growth and manipulations were conducted, and growth media were prepared as previously described.^[@ref20]^ Spore suspensions were generated, by surface scraping, at a density of one 12--14 mm diameter colony per 400 μL of 0.005% Tween-80 (Sigma), grown from point-inoculation on complete media for two days at 37 °C.

Solid media were prepared using polystyrene 100 × 15 mm Petri dishes (KORD-Valmark Labware Products) and Aspergillus nitrogen-free medium (ANM) containing 1% glucose as the carbon source, supplements to repair auxotrophies, and 1% (w/v) skim milk (Kroger Co.) as the nitrogen source.^[@ref14]^

Plate Tests for Degradation of Fungicide-Encapsulated BAPC {#sec4.4}
----------------------------------------------------------

*A. nidulans* spore suspension (50 μL) was spread on the plates using glass beads (≤160 μm) (Sigma) to obtain homogeneous lawns, as described.^[@ref21]^ After 20 min, the TU-BAPC samples described above were spotted at the center of the plates at volumes of 10 and 40 μL. Plates were incubated at 37 °C and analyzed at 24 and 48 h. Three biological replicates were performed.

BAPC Degradation in Liquid Culture Assay {#sec4.5}
----------------------------------------

Two mL liquid cultures comprising supplemented liquid ANM with 1% milk as the nitrogen source and 50 μL of BAPC (1.3 μM) were inoculated with 50 μL of *A. nidulans* spore suspension. The test sample consisted of BAPCs containing a 1.865 M TU solution, and BAPC-free and water-encased BAPC controls were included. The samples, in 25 mL conical flasks, were grown with shaking at 160 oscillations per minute for two days at 37 °C in an orbital shaking incubator. After incubation, conditioned media was filtered through Miracloth (Millipore-Sigma). Filtered media (20 μL) was spotted onto a thick chromatography paper (grade 238, Ahlstrom Filtration Inc.) 5 mm diameter disk and placed in the center of a supplemented ANM-1% milk plate spread with spores 20 min prior. The remaining media was freeze-dried then rehydrated with a small volume (250 μL) to increase its concentration. Concentrated media (20 μL) were then spotted on the chromatography paper disks on milk plates. Three biological replicates were performed.
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